Nexus Pharmaceuticals, LLC announces the U.S Food and Drug Administration (FDA) approval of Tacrolimus Injection 5 mg/mL. Nexus’ Tacrolimus Injection is the first and only vial that will be available.

Evolus said the Food and Drug Administration approved its injectable hyaluronic acid gels, known as Evolysse Form and Evolysse Smooth, in line with management expectations.

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc. GILD gained following the earnings beat and upbeat guidance for 2025, ...

The Senate voted 52-48 on Thursday to confirm Robert F. Kennedy Jr. as Secretary of Health and Human Services, marking a key ...

Unless we support Pennsylvania’s pharmacists and make the profession attractive to the next generation, we could face a ...